488706-20-3

Basic information

• Product Name: 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane
• Synonyms: 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane
• CAS NO: 488706-20-3
• Molecular Weight: 505.701
• Mol File: 488706-20-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane(488706-20-3)
• EPA Substance Registry System: 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane(488706-20-3)

Safety Data

• Hazardous Substances Data: 488706-20-3(Hazardous Substances Data)

Upstream product

• 959149-70-3 C₃₁H₄₁N₃O₄ 
• 959149-71-4 C₃₁H₃₉N₃O₅ 
• 488706-18-9 tris(methyloxycarbonylmethyl)methane 

Relevant articles and documents

Novel Imaging Agents for Fibrosis

The present invention provides a novel imaging agent targeting the mannose-6-phosphate (M6P) receptor suitable for the non-invasive visualization of fibrosis. A method for the preparation of the imaging agent is also provided by the invention, as well as a precursor for use in said method. The invention also provides a pharmaceutical composition comprising the imaging agent and a kit for the preparation of the pharmaceutical composition. In a further aspect, use of the imaging agent for in vivo imaging and in the preparation of a medicament for the diagnosis of a condition in which the mannose-6-phosphate receptor is upregulated is provided.

NOVEL IMAGING AGENTS

The present invention provides a novel imaging agent suitable for the non-invasive visualization of fibrosis. A precursor for the preparation of the imaging agent is also provided by the invention, as well as a pharmaceutical composition comprising the im

NOVEL IMAGING AGENTS FOR CANCER

A novel imaging agent is described which comprises a semaphorin moiety and an imaging moiety. The novel imaging agent of the invention may be used in the diagnostic imaging of cancer and in particular, for targeting angiogenesis or metaplasia. Further aspects of the present invention presented herein include a method for the preparation of the imaging agent, a pharmaceutical composition comprising the imaging agent of the invention and a kit for the preparation of said pharmaceutical.